ENGLEWOOD, Colo., July 28, 2022 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for…
Related Articles

News
Colorado Health Institute CEO leaving after nearly 12 years
As Colorado Health Institute celebrates its 20th anniversary, it will be seeking a new president and CEO. Click here to view original post

News
Think Bioscience Appoints Nicholas A. Saccomano, Ph.D., to its Board of Directors
September 6, 2022
UCBN
News
Comments Off on Think Bioscience Appoints Nicholas A. Saccomano, Ph.D., to its Board of Directors
Think Bioscience bolsters drug development expertise and deepens relationship with Colorado life science ecosystem following a $17M financing. BOULDER, Colo., Sept. 6, 2022 /PRNewswire/ — Think Bioscience (“Think”), a Boulder-based synthetic biology company focused on […]

News
Ginkgo Bioworks handed a DARPA manufacturing contract; Merck hits a primary endpoint for Keytruda in first-line cervical cancer
July 19, 2023
UCBN
News, Syndication
Comments Off on Ginkgo Bioworks handed a DARPA manufacturing contract; Merck hits a primary endpoint for Keytruda in first-line cervical cancer
The Defense Advanced Research Projects Agency (DARPA) is giving Ginkgo Bioworks a 4-year contract worth up to $18 million, to manufacture complex therapeutic proteins. Ginkgo is part of DARPA’s “Reimagining Protein Manufacturing project,” which is […]